HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Axel Ullrich Selected Research
Axel Ullrich Research Topics
Disease
73
Neoplasms (Cancer)
04/2019 - 01/2002
20
Breast Neoplasms (Breast Cancer)
08/2016 - 03/2002
10
Carcinoma (Carcinomatosis)
04/2013 - 02/2002
8
Neoplasm Metastasis (Metastasis)
03/2014 - 09/2005
7
Carcinogenesis
12/2011 - 06/2002
5
Glioma (Gliomas)
03/2016 - 02/2005
4
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2017 - 05/2002
4
Glioblastoma (Glioblastoma Multiforme)
03/2016 - 03/2004
4
Hepatocellular Carcinoma (Hepatoma)
10/2014 - 07/2002
4
Melanoma (Melanoma, Malignant)
07/2012 - 08/2008
3
Insulin Resistance
01/2019 - 09/2011
3
Obesity
01/2018 - 09/2011
3
Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2015 - 11/2002
3
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
08/2003 - 03/2002
2
Type 2 Diabetes Mellitus (MODY)
05/2017 - 01/2016
2
Lymphoma (Lymphomas)
03/2014 - 03/2003
2
Kidney Neoplasms (Kidney Cancer)
12/2013 - 08/2010
2
Ovarian Neoplasms (Ovarian Cancer)
10/2012 - 08/2008
2
Disease Progression
07/2012 - 06/2006
2
Inflammation (Inflammations)
09/2011 - 02/2004
2
Brain Neoplasms (Brain Tumor)
04/2006 - 02/2006
2
Pancreatic Neoplasms (Pancreatic Cancer)
07/2004 - 11/2003
2
Infections
10/2002 - 08/2002
1
Lung Neoplasms (Lung Cancer)
05/2017
1
Insulinoma
01/2017
Drug/Important Bio-Agent (IBA)
15
ErbB Receptors (EGF Receptor)
IBA
04/2014 - 06/2002
13
Phosphotransferases (Kinase)
IBA
07/2018 - 04/2003
13
Ligands
IBA
10/2017 - 11/2002
10
Proteins (Proteins, Gene)
FDA Link
01/2014 - 08/2001
9
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
03/2016 - 02/2005
9
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
10/2014 - 11/2002
8
Pharmaceutical Preparations
IBA
05/2017 - 01/2002
8
Metalloproteases (Metalloproteinases)
IBA
02/2009 - 11/2002
7
Epidermal Growth Factor (EGF)
IBA
08/2010 - 12/2002
6
Type 4 Fibroblast Growth Factor Receptor
IBA
01/2019 - 08/2006
6
Tyrosine Kinase Inhibitors
IBA
01/2017 - 03/2002
6
Small Interfering RNA (siRNA)
IBA
03/2015 - 10/2005
5
Biological Products
IBA
05/2017 - 11/2003
5
tyrosine receptor (receptor, tyrosine)
IBA
08/2016 - 01/2004
5
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2013 - 06/2002
5
Doxorubicin (Adriamycin)
FDA Link
Generic
10/2012 - 06/2004
5
Tyrosine (L-Tyrosine)
FDA Link
10/2006 - 11/2002
4
Axl Receptor Tyrosine Kinase
IBA
10/2017 - 04/2006
4
Messenger RNA (mRNA)
IBA
01/2014 - 11/2003
4
Imatinib Mesylate (Gleevec)
FDA Link
07/2012 - 03/2002
4
Enzymes
IBA
03/2008 - 08/2001
4
G-Protein-Coupled Receptors (Receptors, G Protein Coupled)
IBA
04/2006 - 01/2004
3
Sunitinib (Sutent)
FDA Link
01/2017 - 03/2009
3
Serine (L-Serine)
FDA Link
01/2016 - 08/2005
3
Heparin-binding EGF-like Growth Factor (HB-EGF)
IBA
04/2013 - 06/2004
3
Trastuzumab (Herceptin)
FDA Link
12/2012 - 03/2002
3
Hormones (Hormone)
IBA
12/2011 - 09/2005
3
Disintegrins
IBA
02/2009 - 05/2003
3
Complementary DNA (cDNA)
IBA
02/2009 - 02/2002
3
Neuregulin-1 (Neuregulin 1)
IBA
08/2008 - 02/2005
3
Protein Kinases (Protein Kinase)
IBA
03/2008 - 08/2001
3
orantinib (SU6668)
IBA
08/2005 - 02/2004
3
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
11/2004 - 01/2002
3
lysophosphatidic acid
IBA
11/2004 - 11/2002
2
Lipids
IBA
01/2019 - 04/2006
2
N- (4- (2- amino- 3- chloropyridin- 4- yloxy)- 3- fluorophenyl)- 4- ethoxy- 1- (4- fluorophenyl)- 2- oxo- 1,2- dihydropyridine- 3- carboxamide
IBA
10/2017 - 03/2016
2
salinomycin
IBA
08/2016 - 12/2012
2
Amphiregulin
IBA
03/2015 - 05/2003
2
Sorafenib (BAY 43-9006)
FDA Link
10/2014 - 07/2012
2
Protein Kinase Inhibitors
IBA
07/2012 - 08/2005
2
Monoclonal Antibodies
IBA
02/2012 - 08/2008
2
Biomarkers (Surrogate Marker)
IBA
09/2011 - 05/2008
2
Oncogene Proteins (Oncogene Protein)
IBA
08/2010 - 11/2002
2
Gefitinib (Iressa)
FDA Link
08/2010 - 05/2006
2
Growth Factor Receptors
IBA
01/2010 - 04/2006
2
Nucleotides
IBA
01/2010 - 04/2003
2
DNA (Deoxyribonucleic Acid)
IBA
02/2009 - 11/2002
2
Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)
IBA
01/2009 - 08/2004
2
Elements
IBA
03/2008 - 01/2008
2
Paraffin
IBA
01/2008 - 08/2004
2
Protein Tyrosine Phosphatases
IBA
10/2006 - 03/2004
2
Codon (Codons)
IBA
08/2006 - 06/2006
2
Arginine (L-Arginine)
FDA Link
06/2006 - 02/2002
2
Glycine (Aminoacetic Acid)
FDA Link
Generic
06/2006 - 02/2002
2
Carcinogens
IBA
05/2006 - 11/2002
2
Angiopoietin-1
IBA
02/2006 - 06/2002
2
Peptide Hydrolases (Proteases)
FDA Link
10/2005 - 06/2004
2
Matrix Metalloproteinases (MMPs)
IBA
03/2005 - 12/2002
2
Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)
IBA
02/2005 - 02/2004
2
Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
IBA
02/2005 - 02/2004
2
ADAM17 Protein
IBA
11/2004 - 03/2004
2
Indicators and Reagents (Reagents)
IBA
02/2004 - 05/2002
2
Oxygen (Dioxygen)
IBA
11/2003 - 06/2002
2
Carbachol (Carbastat)
FDA Link
05/2003 - 11/2002
1
Catenins
IBA
04/2019
1
Bile Acids and Salts (Bile Acids)
IBA
01/2019
1
Glucose (Dextrose)
FDA Link
Generic
01/2019
1
Amino Acids
FDA Link
01/2019
1
G-Protein-Coupled Receptor Kinase 5
IBA
01/2018
1
Metformin (Glucophage)
FDA Link
Generic
05/2017
1
Selective Estrogen Receptor Modulators (SERM)
IBA
08/2016
1
Tamoxifen
FDA Link
Generic
08/2016
1
Phenobarbital (Luminal)
FDA Link
08/2016
Therapy/Procedure
31
Therapeutics
05/2017 - 01/2002
7
Drug Therapy (Chemotherapy)
05/2017 - 08/2006